Beurs gesloten -
Nasdaq
22:30:00 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
1,705
USD
|
+6,56%
|
|
+15,99%
|
-54,29%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Marktkapitalisatie
1 |
708,1
|
469,2
|
220,7
|
18,48
|
20,05
|
11,23
|
-
|
Bedrijfswaarde
1 |
708,1
|
390,2
|
113,2
|
18,48
|
20,05
|
11,23
|
11,23
|
K/w-verhouding
|
-7,52
x
|
-4,27
x
|
-2,61
x
|
-0,2
x
|
-2,07
x
|
-0,52
x
|
-0,43
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
31,8
x
|
24,9
x
|
5,7
x
|
0,94
x
|
0,35
x
|
0,88
x
|
8,21
x
|
Bedrijfswaarde/omzet
|
31,8
x
|
24,9
x
|
5,7
x
|
0,94
x
|
0,35
x
|
0,88
x
|
8,21
x
|
Bedrijfswaarde/EBITDA
|
-
|
-4.840.482
x
|
-3.005.223
x
|
-226.823
x
|
-
|
-
|
-
|
Bedrijfswaarde/FCF
|
-
|
-5.144.959
x
|
-6.419.323
x
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-0%
|
-0%
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
7,91
x
|
3,36
x
|
-
|
-
|
-
|
-
|
Aantal aandelen (in duizenden)
|
3.376
|
3.331
|
3.754
|
3.757
|
5.374
|
6.584
|
-
|
Referentieprijs
2 |
209,8
|
140,8
|
58,80
|
4,920
|
3,730
|
1,705
|
1,705
|
Datum van publicatie
|
12/03/20
|
18/03/21
|
28/03/22
|
30/03/23
|
29/03/24
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Omzet
1 |
22,27
|
18,84
|
38,7
|
19,75
|
57,31
|
12,7
|
1,367
|
EBITDA
|
-
|
-96,92
|
-73,44
|
-81,49
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-48,33
|
-100,8
|
-80,07
|
-88,87
|
-10,47
|
-23,67
|
-36,4
|
Operationele Marge
|
-217%
|
-535,11%
|
-206,93%
|
-449,89%
|
-18,26%
|
-186,36%
|
-2.662,91%
|
Resultaat voor belastingen (EBT)
1 |
-69,42
|
-104,9
|
-83,01
|
-92,66
|
-8,135
|
-22,42
|
-34,74
|
Nettowinst (verlies)
1 |
-69,42
|
-104,9
|
-83,01
|
-92,72
|
-8,124
|
-22,42
|
-34,74
|
Nettomarge
|
-311,72%
|
-556,73%
|
-214,51%
|
-469,36%
|
-14,18%
|
-176,5%
|
-2.541,26%
|
WPA
2 |
-27,90
|
-33,00
|
-22,50
|
-24,75
|
-1,800
|
-3,250
|
-3,930
|
Free Cash Flow
|
-
|
-91,19
|
-34,38
|
-
|
-
|
-
|
-
|
FCF-marge
|
-
|
-483,89%
|
-88,85%
|
-
|
-
|
-
|
-
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
12/03/20
|
18/03/21
|
28/03/22
|
30/03/23
|
29/03/24
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Omzet
1 |
2,379
|
17,96
|
8,486
|
4,417
|
4,24
|
2,611
|
36,63
|
6,865
|
6,796
|
7,016
|
5,897
|
6,13
|
0,33
|
0,345
|
EBITDA
|
-27,84
|
-7,499
|
-
|
-21,64
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-29,53
|
-9,301
|
-20,63
|
-23,84
|
-23,67
|
-21,06
|
11,78
|
-11,74
|
-5,137
|
-5,371
|
-4,476
|
-3,545
|
-7,942
|
-7,709
|
Operationele Marge
|
-1.241,24%
|
-51,78%
|
-243,12%
|
-539,71%
|
-558,18%
|
-806,55%
|
32,17%
|
-171,06%
|
-75,59%
|
-76,55%
|
-75,9%
|
-57,83%
|
-2.406,67%
|
-2.234,49%
|
Resultaat voor belastingen (EBT)
1 |
-30,39
|
-10,24
|
-21,61
|
-24,74
|
-24,61
|
-22,02
|
10,84
|
-10,87
|
-4,153
|
-3,959
|
-4,253
|
-3,165
|
-7,552
|
-7,45
|
Nettowinst (verlies)
1 |
-30,39
|
-10,24
|
-21,61
|
-24,74
|
-24,64
|
-22,05
|
10,84
|
-10,87
|
-4,153
|
-3,948
|
-4,253
|
-3,165
|
-7,552
|
-7,45
|
Nettomarge
|
-1.277,3%
|
-57,02%
|
-254,67%
|
-560,22%
|
-581,08%
|
-844,47%
|
29,61%
|
-158,31%
|
-61,11%
|
-56,27%
|
-72,12%
|
-51,63%
|
-2.288,48%
|
-2.159,42%
|
WPA
2 |
-8,100
|
-2,700
|
-5,700
|
-6,600
|
-6,600
|
-5,850
|
2,850
|
-0,1900
|
-0,8200
|
-0,7300
|
-0,7800
|
-0,4700
|
-1,110
|
-0,8900
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
15/11/21
|
28/03/22
|
13/05/22
|
11/08/22
|
10/11/22
|
30/03/23
|
15/05/23
|
10/08/23
|
13/11/23
|
29/03/24
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Nettoschuldpositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
|
-
|
79
|
108
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-91,2
|
-34,4
|
-
|
-
|
-
|
-
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
-129%
|
-133%
|
-
|
-
|
-
|
-
|
ROA (netto-inkomsten/totale activa)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Totale activa
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettoactief per aandeel
|
-
|
17,80
|
17,50
|
-
|
-
|
-
|
-
|
Cashflow per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
7,39
|
4
|
-
|
-
|
-
|
-
|
Capex/omzet
|
-
|
39,23%
|
10,33%
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
12/03/20
|
18/03/21
|
28/03/22
|
30/03/23
|
29/03/24
|
-
|
-
|
Gemiddeld advies Accumuleren Laatste slotkoers
1,705
USD Gemiddelde koersdoel
18
USD Spread / Gemiddelde doel +955,72% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -54,29% | 11,23 mln. | | -2,31% | 103 mld. | | +0,56% | 95,28 mld. | | +1,69% | 22,15 mld. | | -17,37% | 21,02 mld. | | -9,30% | 18,15 mld. | | -41,01% | 16,73 mld. | | -14,85% | 16,05 mld. | | +3,21% | 13,68 mld. | | +33,54% | 12,17 mld. |
Biotherapeutische geneesmiddelen
|